nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—PTGIR—blood vessel—Alzheimer's disease	0.0126	0.119	CbGeAlD
Alprostadil—PTGIR—forebrain—Alzheimer's disease	0.00664	0.063	CbGeAlD
Alprostadil—PTGIR—telencephalon—Alzheimer's disease	0.0061	0.0579	CbGeAlD
Alprostadil—PTGER1—nervous system—Alzheimer's disease	0.00583	0.0553	CbGeAlD
Alprostadil—PTGER1—central nervous system—Alzheimer's disease	0.00562	0.0533	CbGeAlD
Alprostadil—ABCC5—telencephalon—Alzheimer's disease	0.00488	0.0463	CbGeAlD
Alprostadil—SLCO2B1—forebrain—Alzheimer's disease	0.00415	0.0394	CbGeAlD
Alprostadil—SLCO2B1—telencephalon—Alzheimer's disease	0.00382	0.0362	CbGeAlD
Alprostadil—ABCC4—forebrain—Alzheimer's disease	0.00368	0.0349	CbGeAlD
Alprostadil—PTGIR—nervous system—Alzheimer's disease	0.0036	0.0342	CbGeAlD
Alprostadil—PTGIR—central nervous system—Alzheimer's disease	0.00347	0.0329	CbGeAlD
Alprostadil—PTGIR—cerebellum—Alzheimer's disease	0.00339	0.0322	CbGeAlD
Alprostadil—SLCO3A1—nervous system—Alzheimer's disease	0.00318	0.0302	CbGeAlD
Alprostadil—SLCO2A1—nervous system—Alzheimer's disease	0.00315	0.0299	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—Alzheimer's disease	0.00306	0.029	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—Alzheimer's disease	0.00303	0.0288	CbGeAlD
Alprostadil—Sensory loss—Donepezil—Alzheimer's disease	0.00302	0.00476	CcSEcCtD
Alprostadil—Fungal infection—Rivastigmine—Alzheimer's disease	0.00301	0.00474	CcSEcCtD
Alprostadil—SLCO3A1—cerebellum—Alzheimer's disease	0.00299	0.0284	CbGeAlD
Alprostadil—Vasodilation procedure—Donepezil—Alzheimer's disease	0.00298	0.00469	CcSEcCtD
Alprostadil—Vasodilation—Donepezil—Alzheimer's disease	0.00298	0.00469	CcSEcCtD
Alprostadil—Accidental injury—Donepezil—Alzheimer's disease	0.00296	0.00466	CcSEcCtD
Alprostadil—Hyperbilirubinaemia—Donepezil—Alzheimer's disease	0.00288	0.00453	CcSEcCtD
Alprostadil—Numbness—Memantine—Alzheimer's disease	0.00287	0.00451	CcSEcCtD
Alprostadil—Apnoea—Memantine—Alzheimer's disease	0.0028	0.00442	CcSEcCtD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS1—Alzheimer's disease	0.00279	0.636	CrCbGaD
Alprostadil—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.00277	0.00436	CcSEcCtD
Alprostadil—PTGIR—brain—Alzheimer's disease	0.00275	0.0261	CbGeAlD
Alprostadil—Sensory loss—Memantine—Alzheimer's disease	0.00274	0.00432	CcSEcCtD
Alprostadil—Apnoea—Rivastigmine—Alzheimer's disease	0.00274	0.00432	CcSEcCtD
Alprostadil—ABCC5—cerebellum—Alzheimer's disease	0.00271	0.0257	CbGeAlD
Alprostadil—Accidental injury—Memantine—Alzheimer's disease	0.00269	0.00423	CcSEcCtD
Alprostadil—Injury—Galantamine—Alzheimer's disease	0.00267	0.0042	CcSEcCtD
Alprostadil—Hyperbilirubinaemia—Memantine—Alzheimer's disease	0.00261	0.00412	CcSEcCtD
Alprostadil—Musculoskeletal stiffness—Rivastigmine—Alzheimer's disease	0.00259	0.00408	CcSEcCtD
Alprostadil—Wheezing—Donepezil—Alzheimer's disease	0.00254	0.004	CcSEcCtD
Alprostadil—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.00251	0.00396	CcSEcCtD
Alprostadil—Lethargy—Galantamine—Alzheimer's disease	0.0025	0.00394	CcSEcCtD
Alprostadil—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00246	0.00387	CcSEcCtD
Alprostadil—Pain in extremity—Galantamine—Alzheimer's disease	0.00245	0.00386	CcSEcCtD
Alprostadil—SLCO3A1—brain—Alzheimer's disease	0.00243	0.0231	CbGeAlD
Alprostadil—SLCO2A1—brain—Alzheimer's disease	0.00241	0.0228	CbGeAlD
Alprostadil—Cramps of lower extremities—Donepezil—Alzheimer's disease	0.0024	0.00379	CcSEcCtD
Alprostadil—Ecchymosis—Donepezil—Alzheimer's disease	0.00237	0.00373	CcSEcCtD
Alprostadil—Hyperkalaemia—Memantine—Alzheimer's disease	0.00233	0.00368	CcSEcCtD
Alprostadil—Influenza like illness—Memantine—Alzheimer's disease	0.00231	0.00363	CcSEcCtD
Alprostadil—Abnormal vision—Donepezil—Alzheimer's disease	0.00228	0.00359	CcSEcCtD
Alprostadil—Sepsis—Donepezil—Alzheimer's disease	0.00227	0.00358	CcSEcCtD
Alprostadil—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00226	0.00356	CcSEcCtD
Alprostadil—SLCO2B1—nervous system—Alzheimer's disease	0.00225	0.0214	CbGeAlD
Alprostadil—Hypokalaemia—Galantamine—Alzheimer's disease	0.00223	0.00351	CcSEcCtD
Alprostadil—ABCC5—brain—Alzheimer's disease	0.0022	0.0209	CbGeAlD
Alprostadil—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00218	0.00344	CcSEcCtD
Alprostadil—SLCO2B1—central nervous system—Alzheimer's disease	0.00217	0.0206	CbGeAlD
Alprostadil—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.00214	0.00336	CcSEcCtD
Alprostadil—SLCO2B1—cerebellum—Alzheimer's disease	0.00212	0.0201	CbGeAlD
Alprostadil—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00209	0.0033	CcSEcCtD
Alprostadil—Abnormal vision—Memantine—Alzheimer's disease	0.00207	0.00326	CcSEcCtD
Alprostadil—Injury—Donepezil—Alzheimer's disease	0.00207	0.00326	CcSEcCtD
Alprostadil—Sepsis—Memantine—Alzheimer's disease	0.00206	0.00325	CcSEcCtD
Alprostadil—Bronchitis—Galantamine—Alzheimer's disease	0.00204	0.00321	CcSEcCtD
Alprostadil—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00203	0.00319	CcSEcCtD
Alprostadil—Sepsis—Rivastigmine—Alzheimer's disease	0.00202	0.00318	CcSEcCtD
Alprostadil—ABCC4—nervous system—Alzheimer's disease	0.002	0.0189	CbGeAlD
Alprostadil—Diabetes mellitus—Memantine—Alzheimer's disease	0.00198	0.00312	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00197	0.0031	CcSEcCtD
Alprostadil—Pollakiuria—Galantamine—Alzheimer's disease	0.00196	0.00308	CcSEcCtD
Alprostadil—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00195	0.00307	CcSEcCtD
Alprostadil—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.00194	0.00306	CcSEcCtD
Alprostadil—ABCC4—central nervous system—Alzheimer's disease	0.00192	0.0182	CbGeAlD
Alprostadil—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00191	0.00301	CcSEcCtD
Alprostadil—Cardiac failure congestive—Memantine—Alzheimer's disease	0.0019	0.003	CcSEcCtD
Alprostadil—Injury—Memantine—Alzheimer's disease	0.00188	0.00296	CcSEcCtD
Alprostadil—Renal failure—Galantamine—Alzheimer's disease	0.00186	0.00292	CcSEcCtD
Alprostadil—Urinary tract infection—Galantamine—Alzheimer's disease	0.00184	0.00289	CcSEcCtD
Alprostadil—Injury—Rivastigmine—Alzheimer's disease	0.00184	0.00289	CcSEcCtD
Alprostadil—Haematuria—Galantamine—Alzheimer's disease	0.0018	0.00284	CcSEcCtD
Alprostadil—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00178	0.0028	CcSEcCtD
Alprostadil—Hypoglycaemia—Memantine—Alzheimer's disease	0.00177	0.00278	CcSEcCtD
Alprostadil—Lethargy—Memantine—Alzheimer's disease	0.00176	0.00277	CcSEcCtD
Alprostadil—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00173	0.00272	CcSEcCtD
Alprostadil—Hypokalaemia—Donepezil—Alzheimer's disease	0.00173	0.00272	CcSEcCtD
Alprostadil—Bradycardia—Galantamine—Alzheimer's disease	0.00173	0.00272	CcSEcCtD
Alprostadil—Pain in extremity—Memantine—Alzheimer's disease	0.00172	0.00272	CcSEcCtD
Alprostadil—SLCO2B1—brain—Alzheimer's disease	0.00172	0.0163	CbGeAlD
Alprostadil—Haemoglobin—Galantamine—Alzheimer's disease	0.0017	0.00268	CcSEcCtD
Alprostadil—Rhinitis—Galantamine—Alzheimer's disease	0.0017	0.00268	CcSEcCtD
Alprostadil—Haemorrhage—Galantamine—Alzheimer's disease	0.0017	0.00267	CcSEcCtD
Alprostadil—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00169	0.00266	CcSEcCtD
Alprostadil—Urethral disorder—Galantamine—Alzheimer's disease	0.00166	0.00262	CcSEcCtD
Alprostadil—Influenza—Donepezil—Alzheimer's disease	0.00164	0.00259	CcSEcCtD
Alprostadil—Cardiac arrest—Memantine—Alzheimer's disease	0.00164	0.00258	CcSEcCtD
Alprostadil—Visual impairment—Galantamine—Alzheimer's disease	0.00163	0.00257	CcSEcCtD
Alprostadil—Blood creatinine increased—Memantine—Alzheimer's disease	0.00162	0.00255	CcSEcCtD
Alprostadil—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.0016	0.00253	CcSEcCtD
Alprostadil—Sweating increased—Donepezil—Alzheimer's disease	0.0016	0.00252	CcSEcCtD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—Alzheimer's disease	0.00159	0.364	CrCbGaD
Alprostadil—Bronchitis—Donepezil—Alzheimer's disease	0.00158	0.00249	CcSEcCtD
Alprostadil—Flushing—Galantamine—Alzheimer's disease	0.00157	0.00248	CcSEcCtD
Alprostadil—Hypokalaemia—Memantine—Alzheimer's disease	0.00157	0.00247	CcSEcCtD
Alprostadil—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00154	0.00242	CcSEcCtD
Alprostadil—ABCC4—brain—Alzheimer's disease	0.00153	0.0145	CbGeAlD
Alprostadil—Pollakiuria—Donepezil—Alzheimer's disease	0.00152	0.00239	CcSEcCtD
Alprostadil—Influenza—Memantine—Alzheimer's disease	0.00149	0.00235	CcSEcCtD
Alprostadil—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00148	0.00233	CcSEcCtD
Alprostadil—Sweating increased—Memantine—Alzheimer's disease	0.00145	0.00229	CcSEcCtD
Alprostadil—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00144	0.00227	CcSEcCtD
Alprostadil—Renal failure—Donepezil—Alzheimer's disease	0.00144	0.00227	CcSEcCtD
Alprostadil—Myocardial infarction—Donepezil—Alzheimer's disease	0.00143	0.00226	CcSEcCtD
Alprostadil—Nervousness—Galantamine—Alzheimer's disease	0.00143	0.00226	CcSEcCtD
Alprostadil—Bronchitis—Memantine—Alzheimer's disease	0.00143	0.00226	CcSEcCtD
Alprostadil—Back pain—Galantamine—Alzheimer's disease	0.00143	0.00225	CcSEcCtD
Alprostadil—Urinary tract infection—Donepezil—Alzheimer's disease	0.00142	0.00224	CcSEcCtD
Alprostadil—Sweating increased—Rivastigmine—Alzheimer's disease	0.00142	0.00224	CcSEcCtD
Alprostadil—Muscle spasms—Galantamine—Alzheimer's disease	0.00142	0.00224	CcSEcCtD
Alprostadil—Bronchitis—Rivastigmine—Alzheimer's disease	0.0014	0.00221	CcSEcCtD
Alprostadil—Haematuria—Donepezil—Alzheimer's disease	0.0014	0.0022	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00139	0.00218	CcSEcCtD
Alprostadil—Pollakiuria—Memantine—Alzheimer's disease	0.00138	0.00217	CcSEcCtD
Alprostadil—Anaemia—Galantamine—Alzheimer's disease	0.00136	0.00215	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00136	0.00213	CcSEcCtD
Alprostadil—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00135	0.00212	CcSEcCtD
Alprostadil—Hyperglycaemia—Memantine—Alzheimer's disease	0.00134	0.00212	CcSEcCtD
Alprostadil—Bradycardia—Donepezil—Alzheimer's disease	0.00134	0.00211	CcSEcCtD
Alprostadil—Syncope—Galantamine—Alzheimer's disease	0.00132	0.00209	CcSEcCtD
Alprostadil—Haemoglobin—Donepezil—Alzheimer's disease	0.00132	0.00208	CcSEcCtD
Alprostadil—Rhinitis—Donepezil—Alzheimer's disease	0.00132	0.00208	CcSEcCtD
Alprostadil—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00132	0.00207	CcSEcCtD
Alprostadil—Haemorrhage—Donepezil—Alzheimer's disease	0.00131	0.00207	CcSEcCtD
Alprostadil—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00131	0.00206	CcSEcCtD
Alprostadil—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00131	0.00206	CcSEcCtD
Alprostadil—Renal failure—Memantine—Alzheimer's disease	0.00131	0.00206	CcSEcCtD
Alprostadil—Pharyngitis—Donepezil—Alzheimer's disease	0.0013	0.00205	CcSEcCtD
Alprostadil—Myocardial infarction—Memantine—Alzheimer's disease	0.0013	0.00205	CcSEcCtD
Alprostadil—Loss of consciousness—Galantamine—Alzheimer's disease	0.0013	0.00204	CcSEcCtD
Alprostadil—Urinary tract infection—Memantine—Alzheimer's disease	0.00129	0.00204	CcSEcCtD
Alprostadil—Urethral disorder—Donepezil—Alzheimer's disease	0.00129	0.00203	CcSEcCtD
Alprostadil—Cough—Galantamine—Alzheimer's disease	0.00129	0.00203	CcSEcCtD
Alprostadil—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00128	0.00202	CcSEcCtD
Alprostadil—Convulsion—Galantamine—Alzheimer's disease	0.00128	0.00201	CcSEcCtD
Alprostadil—Renal failure—Rivastigmine—Alzheimer's disease	0.00128	0.00201	CcSEcCtD
Alprostadil—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00127	0.00201	CcSEcCtD
Alprostadil—Hypertension—Galantamine—Alzheimer's disease	0.00127	0.00201	CcSEcCtD
Alprostadil—Haematuria—Memantine—Alzheimer's disease	0.00127	0.002	CcSEcCtD
Alprostadil—Visual impairment—Donepezil—Alzheimer's disease	0.00127	0.00199	CcSEcCtD
Alprostadil—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00126	0.00199	CcSEcCtD
Alprostadil—Sinusitis—Memantine—Alzheimer's disease	0.00125	0.00196	CcSEcCtD
Alprostadil—Discomfort—Galantamine—Alzheimer's disease	0.00124	0.00196	CcSEcCtD
Alprostadil—Haematuria—Rivastigmine—Alzheimer's disease	0.00124	0.00195	CcSEcCtD
Alprostadil—Dry mouth—Galantamine—Alzheimer's disease	0.00123	0.00194	CcSEcCtD
Alprostadil—Sinusitis—Rivastigmine—Alzheimer's disease	0.00122	0.00192	CcSEcCtD
Alprostadil—Bradycardia—Memantine—Alzheimer's disease	0.00121	0.00191	CcSEcCtD
Alprostadil—Haemoglobin—Memantine—Alzheimer's disease	0.0012	0.00189	CcSEcCtD
Alprostadil—Rhinitis—Memantine—Alzheimer's disease	0.0012	0.00188	CcSEcCtD
Alprostadil—Haemorrhage—Memantine—Alzheimer's disease	0.00119	0.00188	CcSEcCtD
Alprostadil—Bradycardia—Rivastigmine—Alzheimer's disease	0.00119	0.00187	CcSEcCtD
Alprostadil—Hypoaesthesia—Memantine—Alzheimer's disease	0.00119	0.00187	CcSEcCtD
Alprostadil—Shock—Galantamine—Alzheimer's disease	0.00119	0.00187	CcSEcCtD
Alprostadil—Pharyngitis—Memantine—Alzheimer's disease	0.00118	0.00187	CcSEcCtD
Alprostadil—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00118	0.00186	CcSEcCtD
Alprostadil—Tachycardia—Galantamine—Alzheimer's disease	0.00118	0.00185	CcSEcCtD
Alprostadil—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00117	0.00185	CcSEcCtD
Alprostadil—Rhinitis—Rivastigmine—Alzheimer's disease	0.00117	0.00184	CcSEcCtD
Alprostadil—Skin disorder—Galantamine—Alzheimer's disease	0.00117	0.00184	CcSEcCtD
Alprostadil—Urethral disorder—Memantine—Alzheimer's disease	0.00117	0.00184	CcSEcCtD
Alprostadil—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00117	0.00184	CcSEcCtD
Alprostadil—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00116	0.00183	CcSEcCtD
Alprostadil—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00116	0.00183	CcSEcCtD
Alprostadil—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00116	0.00182	CcSEcCtD
Alprostadil—Visual impairment—Memantine—Alzheimer's disease	0.00115	0.00181	CcSEcCtD
Alprostadil—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00114	0.0018	CcSEcCtD
Alprostadil—Erythema—Donepezil—Alzheimer's disease	0.00114	0.0018	CcSEcCtD
Alprostadil—Hypotension—Galantamine—Alzheimer's disease	0.00113	0.00177	CcSEcCtD
Alprostadil—Visual impairment—Rivastigmine—Alzheimer's disease	0.00112	0.00177	CcSEcCtD
Alprostadil—Nervousness—Donepezil—Alzheimer's disease	0.00111	0.00175	CcSEcCtD
Alprostadil—Flushing—Memantine—Alzheimer's disease	0.00111	0.00174	CcSEcCtD
Alprostadil—Back pain—Donepezil—Alzheimer's disease	0.00111	0.00174	CcSEcCtD
Alprostadil—Muscle spasms—Donepezil—Alzheimer's disease	0.0011	0.00173	CcSEcCtD
Alprostadil—Flushing—Rivastigmine—Alzheimer's disease	0.00108	0.00171	CcSEcCtD
Alprostadil—Dyspepsia—Galantamine—Alzheimer's disease	0.00106	0.00167	CcSEcCtD
Alprostadil—Anaemia—Donepezil—Alzheimer's disease	0.00106	0.00167	CcSEcCtD
Alprostadil—Syncope—Donepezil—Alzheimer's disease	0.00103	0.00162	CcSEcCtD
Alprostadil—Erythema—Rivastigmine—Alzheimer's disease	0.00102	0.0016	CcSEcCtD
Alprostadil—Nervousness—Memantine—Alzheimer's disease	0.00101	0.00159	CcSEcCtD
Alprostadil—Loss of consciousness—Donepezil—Alzheimer's disease	0.00101	0.00158	CcSEcCtD
Alprostadil—Back pain—Memantine—Alzheimer's disease	0.001	0.00158	CcSEcCtD
Alprostadil—Cough—Donepezil—Alzheimer's disease	0.000998	0.00157	CcSEcCtD
Alprostadil—Feeling abnormal—Galantamine—Alzheimer's disease	0.000993	0.00156	CcSEcCtD
Alprostadil—Convulsion—Donepezil—Alzheimer's disease	0.000991	0.00156	CcSEcCtD
Alprostadil—Hypertension—Donepezil—Alzheimer's disease	0.000988	0.00156	CcSEcCtD
Alprostadil—Nervousness—Rivastigmine—Alzheimer's disease	0.000987	0.00155	CcSEcCtD
Alprostadil—Back pain—Rivastigmine—Alzheimer's disease	0.000983	0.00155	CcSEcCtD
Alprostadil—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000977	0.00154	CcSEcCtD
Alprostadil—Discomfort—Donepezil—Alzheimer's disease	0.000962	0.00152	CcSEcCtD
Alprostadil—Anaemia—Memantine—Alzheimer's disease	0.00096	0.00151	CcSEcCtD
Alprostadil—Dry mouth—Donepezil—Alzheimer's disease	0.000952	0.0015	CcSEcCtD
Alprostadil—Abdominal pain—Galantamine—Alzheimer's disease	0.000952	0.0015	CcSEcCtD
Alprostadil—Body temperature increased—Galantamine—Alzheimer's disease	0.000952	0.0015	CcSEcCtD
Alprostadil—Anaemia—Rivastigmine—Alzheimer's disease	0.000939	0.00148	CcSEcCtD
Alprostadil—Oedema—Donepezil—Alzheimer's disease	0.000934	0.00147	CcSEcCtD
Alprostadil—Syncope—Memantine—Alzheimer's disease	0.000931	0.00147	CcSEcCtD
Alprostadil—Infection—Donepezil—Alzheimer's disease	0.000927	0.00146	CcSEcCtD
Alprostadil—Shock—Donepezil—Alzheimer's disease	0.000919	0.00145	CcSEcCtD
Alprostadil—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000914	0.00144	CcSEcCtD
Alprostadil—Loss of consciousness—Memantine—Alzheimer's disease	0.000913	0.00144	CcSEcCtD
Alprostadil—Syncope—Rivastigmine—Alzheimer's disease	0.000911	0.00144	CcSEcCtD
Alprostadil—Cough—Memantine—Alzheimer's disease	0.000906	0.00143	CcSEcCtD
Alprostadil—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000903	0.00142	CcSEcCtD
Alprostadil—Convulsion—Memantine—Alzheimer's disease	0.0009	0.00142	CcSEcCtD
Alprostadil—Hypertension—Memantine—Alzheimer's disease	0.000897	0.00141	CcSEcCtD
Alprostadil—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000893	0.00141	CcSEcCtD
Alprostadil—Cough—Rivastigmine—Alzheimer's disease	0.000887	0.0014	CcSEcCtD
Alprostadil—Convulsion—Rivastigmine—Alzheimer's disease	0.00088	0.00139	CcSEcCtD
Alprostadil—Hypertension—Rivastigmine—Alzheimer's disease	0.000877	0.00138	CcSEcCtD
Alprostadil—Discomfort—Memantine—Alzheimer's disease	0.000874	0.00138	CcSEcCtD
Alprostadil—Hypotension—Donepezil—Alzheimer's disease	0.000872	0.00137	CcSEcCtD
Alprostadil—Dry mouth—Memantine—Alzheimer's disease	0.000865	0.00136	CcSEcCtD
Alprostadil—Asthenia—Galantamine—Alzheimer's disease	0.000864	0.00136	CcSEcCtD
Alprostadil—Discomfort—Rivastigmine—Alzheimer's disease	0.000855	0.00135	CcSEcCtD
Alprostadil—Oedema—Memantine—Alzheimer's disease	0.000848	0.00134	CcSEcCtD
Alprostadil—Dry mouth—Rivastigmine—Alzheimer's disease	0.000846	0.00133	CcSEcCtD
Alprostadil—Infection—Memantine—Alzheimer's disease	0.000842	0.00133	CcSEcCtD
Alprostadil—Shock—Memantine—Alzheimer's disease	0.000834	0.00131	CcSEcCtD
Alprostadil—Thrombocytopenia—Memantine—Alzheimer's disease	0.00083	0.00131	CcSEcCtD
Alprostadil—Oedema—Rivastigmine—Alzheimer's disease	0.000829	0.00131	CcSEcCtD
Alprostadil—Tachycardia—Memantine—Alzheimer's disease	0.000827	0.0013	CcSEcCtD
Alprostadil—Diarrhoea—Galantamine—Alzheimer's disease	0.000824	0.0013	CcSEcCtD
Alprostadil—Infection—Rivastigmine—Alzheimer's disease	0.000824	0.0013	CcSEcCtD
Alprostadil—Skin disorder—Memantine—Alzheimer's disease	0.000823	0.0013	CcSEcCtD
Alprostadil—Dyspepsia—Donepezil—Alzheimer's disease	0.000822	0.00129	CcSEcCtD
Alprostadil—Hyperhidrosis—Memantine—Alzheimer's disease	0.000819	0.00129	CcSEcCtD
Alprostadil—Shock—Rivastigmine—Alzheimer's disease	0.000816	0.00129	CcSEcCtD
Alprostadil—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000812	0.00128	CcSEcCtD
Alprostadil—Tachycardia—Rivastigmine—Alzheimer's disease	0.000809	0.00127	CcSEcCtD
Alprostadil—Skin disorder—Rivastigmine—Alzheimer's disease	0.000805	0.00127	CcSEcCtD
Alprostadil—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000802	0.00126	CcSEcCtD
Alprostadil—Pain—Donepezil—Alzheimer's disease	0.000798	0.00126	CcSEcCtD
Alprostadil—Dizziness—Galantamine—Alzheimer's disease	0.000797	0.00125	CcSEcCtD
Alprostadil—Hypotension—Memantine—Alzheimer's disease	0.000792	0.00125	CcSEcCtD
Alprostadil—Hypotension—Rivastigmine—Alzheimer's disease	0.000775	0.00122	CcSEcCtD
Alprostadil—Feeling abnormal—Donepezil—Alzheimer's disease	0.000769	0.00121	CcSEcCtD
Alprostadil—Rash—Galantamine—Alzheimer's disease	0.00076	0.0012	CcSEcCtD
Alprostadil—Dermatitis—Galantamine—Alzheimer's disease	0.000759	0.0012	CcSEcCtD
Alprostadil—Headache—Galantamine—Alzheimer's disease	0.000755	0.00119	CcSEcCtD
Alprostadil—Dyspepsia—Memantine—Alzheimer's disease	0.000746	0.00118	CcSEcCtD
Alprostadil—Body temperature increased—Donepezil—Alzheimer's disease	0.000738	0.00116	CcSEcCtD
Alprostadil—Abdominal pain—Donepezil—Alzheimer's disease	0.000738	0.00116	CcSEcCtD
Alprostadil—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00073	0.00115	CcSEcCtD
Alprostadil—Pain—Memantine—Alzheimer's disease	0.000725	0.00114	CcSEcCtD
Alprostadil—Nausea—Galantamine—Alzheimer's disease	0.000716	0.00113	CcSEcCtD
Alprostadil—Pain—Rivastigmine—Alzheimer's disease	0.000709	0.00112	CcSEcCtD
Alprostadil—Feeling abnormal—Memantine—Alzheimer's disease	0.000699	0.0011	CcSEcCtD
Alprostadil—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000683	0.00108	CcSEcCtD
Alprostadil—Abdominal pain—Memantine—Alzheimer's disease	0.00067	0.00106	CcSEcCtD
Alprostadil—Body temperature increased—Memantine—Alzheimer's disease	0.00067	0.00106	CcSEcCtD
Alprostadil—Asthenia—Donepezil—Alzheimer's disease	0.00067	0.00106	CcSEcCtD
Alprostadil—Pruritus—Donepezil—Alzheimer's disease	0.000661	0.00104	CcSEcCtD
Alprostadil—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000656	0.00103	CcSEcCtD
Alprostadil—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000656	0.00103	CcSEcCtD
Alprostadil—Diarrhoea—Donepezil—Alzheimer's disease	0.000639	0.00101	CcSEcCtD
Alprostadil—Dizziness—Donepezil—Alzheimer's disease	0.000617	0.000972	CcSEcCtD
Alprostadil—Asthenia—Memantine—Alzheimer's disease	0.000608	0.000958	CcSEcCtD
Alprostadil—Pruritus—Memantine—Alzheimer's disease	0.0006	0.000945	CcSEcCtD
Alprostadil—Asthenia—Rivastigmine—Alzheimer's disease	0.000595	0.000937	CcSEcCtD
Alprostadil—Rash—Donepezil—Alzheimer's disease	0.000589	0.000927	CcSEcCtD
Alprostadil—Dermatitis—Donepezil—Alzheimer's disease	0.000588	0.000926	CcSEcCtD
Alprostadil—Pruritus—Rivastigmine—Alzheimer's disease	0.000587	0.000924	CcSEcCtD
Alprostadil—Headache—Donepezil—Alzheimer's disease	0.000585	0.000921	CcSEcCtD
Alprostadil—Diarrhoea—Memantine—Alzheimer's disease	0.00058	0.000914	CcSEcCtD
Alprostadil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000567	0.000894	CcSEcCtD
Alprostadil—Dizziness—Memantine—Alzheimer's disease	0.000561	0.000883	CcSEcCtD
Alprostadil—Nausea—Donepezil—Alzheimer's disease	0.000555	0.000874	CcSEcCtD
Alprostadil—Dizziness—Rivastigmine—Alzheimer's disease	0.000548	0.000864	CcSEcCtD
Alprostadil—Rash—Memantine—Alzheimer's disease	0.000534	0.000842	CcSEcCtD
Alprostadil—Dermatitis—Memantine—Alzheimer's disease	0.000534	0.000841	CcSEcCtD
Alprostadil—Headache—Memantine—Alzheimer's disease	0.000531	0.000836	CcSEcCtD
Alprostadil—Rash—Rivastigmine—Alzheimer's disease	0.000523	0.000824	CcSEcCtD
Alprostadil—Dermatitis—Rivastigmine—Alzheimer's disease	0.000522	0.000823	CcSEcCtD
Alprostadil—Headache—Rivastigmine—Alzheimer's disease	0.00052	0.000818	CcSEcCtD
Alprostadil—Nausea—Memantine—Alzheimer's disease	0.000504	0.000793	CcSEcCtD
Alprostadil—Nausea—Rivastigmine—Alzheimer's disease	0.000493	0.000776	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00016	0.000625	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NCSTN—Alzheimer's disease	0.000158	0.00062	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000158	0.00062	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PSEN2—Alzheimer's disease	0.000158	0.000619	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—F2—Alzheimer's disease	0.000158	0.000618	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000157	0.000616	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CST3—Alzheimer's disease	0.000155	0.000606	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LRP1—Alzheimer's disease	0.000154	0.000605	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LRP1—Alzheimer's disease	0.000154	0.000605	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TPI1—Alzheimer's disease	0.000153	0.000601	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CHAT—Alzheimer's disease	0.000153	0.000601	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GAB2—Alzheimer's disease	0.000153	0.000599	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NTRK2—Alzheimer's disease	0.000153	0.000599	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SST—Alzheimer's disease	0.000153	0.000599	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CALM1—Alzheimer's disease	0.000152	0.000597	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000152	0.000594	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GFAP—Alzheimer's disease	0.000151	0.000591	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GAL—Alzheimer's disease	0.000151	0.000591	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GFAP—Alzheimer's disease	0.000151	0.000591	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GAL—Alzheimer's disease	0.000151	0.000591	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APP—Alzheimer's disease	0.000149	0.000584	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IGF1—Alzheimer's disease	0.000148	0.000579	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MAOB—Alzheimer's disease	0.000147	0.000576	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IAPP—Alzheimer's disease	0.000145	0.000566	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SOD1—Alzheimer's disease	0.000144	0.000566	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—F2—Alzheimer's disease	0.000143	0.000561	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TGFB1—Alzheimer's disease	0.000143	0.000559	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GAPDH—Alzheimer's disease	0.000142	0.000554	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PLCB1—Alzheimer's disease	0.000141	0.000551	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IGF2—Alzheimer's disease	0.000137	0.000537	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—A2M—Alzheimer's disease	0.000137	0.000535	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—NOS3—Alzheimer's disease	0.000134	0.000525	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ENO1—Alzheimer's disease	0.000133	0.000521	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—A2M—Alzheimer's disease	0.000133	0.000521	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—A2M—Alzheimer's disease	0.000133	0.000521	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PPP3CA—Alzheimer's disease	0.000132	0.000519	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000132	0.000518	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGFR—Alzheimer's disease	0.000131	0.000514	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000131	0.000513	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000131	0.000513	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CREB1—Alzheimer's disease	0.000131	0.000511	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000129	0.000504	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000129	0.000504	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADAM10—Alzheimer's disease	0.000128	0.000502	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL2—Alzheimer's disease	0.000128	0.0005	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GAB2—Alzheimer's disease	0.000127	0.000497	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GSK3A—Alzheimer's disease	0.000126	0.000493	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000124	0.000486	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000124	0.000486	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APP—Alzheimer's disease	0.000124	0.000485	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PRKCG—Alzheimer's disease	0.000124	0.000484	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000122	0.000476	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000122	0.000476	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—S100B—Alzheimer's disease	0.000121	0.000475	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.00012	0.000471	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000119	0.000466	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000119	0.000466	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ACHE—Alzheimer's disease	0.000119	0.000466	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NPY—Alzheimer's disease	0.000119	0.000464	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NPY—Alzheimer's disease	0.000119	0.000464	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IAPP—Alzheimer's disease	0.000118	0.000461	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IAPP—Alzheimer's disease	0.000118	0.000461	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—INPP5D—Alzheimer's disease	0.000118	0.00046	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF2—Alzheimer's disease	0.000116	0.000452	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CRH—Alzheimer's disease	0.000114	0.000448	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CRH—Alzheimer's disease	0.000114	0.000448	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR5—Alzheimer's disease	0.000113	0.000442	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000113	0.000442	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1R—Alzheimer's disease	0.000112	0.000437	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	0.000112	0.000437	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ENO1—Alzheimer's disease	0.000111	0.000437	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS1—Alzheimer's disease	0.000111	0.000437	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR2A—Alzheimer's disease	0.00011	0.000432	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.00011	0.000432	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2D6—Alzheimer's disease	0.000109	0.000428	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NPS—Alzheimer's disease	0.000108	0.000424	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NPS—Alzheimer's disease	0.000108	0.000424	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PLAU—Alzheimer's disease	0.000108	0.000423	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000108	0.000422	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000108	0.000422	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—LPL—Alzheimer's disease	0.000107	0.000419	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—CALM1—Alzheimer's disease	0.000107	0.000419	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—F2—Alzheimer's disease	0.000107	0.000417	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—F2—Alzheimer's disease	0.000107	0.000417	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ADAM10—Alzheimer's disease	0.000106	0.000417	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTK2B—Alzheimer's disease	0.000106	0.000416	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000106	0.000416	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MEF2C—Alzheimer's disease	0.000106	0.000416	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—CAV1—Alzheimer's disease	0.000106	0.000414	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PRKCG—Alzheimer's disease	0.000104	0.000408	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—BCHE—Alzheimer's disease	0.000104	0.000406	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GAB2—Alzheimer's disease	0.000103	0.000405	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GAB2—Alzheimer's disease	0.000103	0.000405	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SST—Alzheimer's disease	0.000103	0.000405	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SST—Alzheimer's disease	0.000103	0.000405	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000103	0.000405	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000103	0.000405	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000103	0.000403	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CALM1—Alzheimer's disease	0.000103	0.000403	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000103	0.000401	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000103	0.000401	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	0.000102	0.000401	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGF—Alzheimer's disease	0.000101	0.000397	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APP—Alzheimer's disease	0.000101	0.000395	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APP—Alzheimer's disease	0.000101	0.000395	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—F2—Alzheimer's disease	0.000101	0.000394	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS2—Alzheimer's disease	9.93e-05	0.000389	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR5—Alzheimer's disease	9.87e-05	0.000386	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PLCB1—Alzheimer's disease	9.78e-05	0.000383	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—F2—Alzheimer's disease	9.68e-05	0.000379	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—F2—Alzheimer's disease	9.68e-05	0.000379	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR2A—Alzheimer's disease	9.65e-05	0.000378	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—Alzheimer's disease	9.65e-05	0.000378	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PLCB1—Alzheimer's disease	9.51e-05	0.000372	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PLCB1—Alzheimer's disease	9.51e-05	0.000372	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ABCA1—Alzheimer's disease	9.48e-05	0.000371	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CALM1—Alzheimer's disease	9.01e-05	0.000353	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—LEP—Alzheimer's disease	8.98e-05	0.000351	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOE—Alzheimer's disease	8.98e-05	0.000351	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CAV1—Alzheimer's disease	8.89e-05	0.000348	CbGpPWpGaD
Alprostadil—ABCC5—Disease—LPL—Alzheimer's disease	8.88e-05	0.000348	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGFR—Alzheimer's disease	8.87e-05	0.000347	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGFR—Alzheimer's disease	8.87e-05	0.000347	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TGFB1—Alzheimer's disease	8.86e-05	0.000347	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CREB1—Alzheimer's disease	8.82e-05	0.000345	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CREB1—Alzheimer's disease	8.82e-05	0.000345	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IGF1—Alzheimer's disease	8.81e-05	0.000345	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADAM10—Alzheimer's disease	8.67e-05	0.000339	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADAM10—Alzheimer's disease	8.67e-05	0.000339	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PRKCG—Alzheimer's disease	8.64e-05	0.000338	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL2—Alzheimer's disease	8.63e-05	0.000338	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL2—Alzheimer's disease	8.63e-05	0.000338	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ESR1—Alzheimer's disease	8.57e-05	0.000336	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—F2—Alzheimer's disease	8.46e-05	0.000331	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOTCH1—Alzheimer's disease	8.28e-05	0.000324	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—S100B—Alzheimer's disease	8.2e-05	0.000321	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—S100B—Alzheimer's disease	8.2e-05	0.000321	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—Alzheimer's disease	8.18e-05	0.00032	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARGC1A—Alzheimer's disease	8.17e-05	0.00032	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMOX1—Alzheimer's disease	8.13e-05	0.000318	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—Alzheimer's disease	8e-05	0.000313	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—Alzheimer's disease	7.99e-05	0.000313	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF2—Alzheimer's disease	7.8e-05	0.000306	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF2—Alzheimer's disease	7.8e-05	0.000306	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GSK3B—Alzheimer's disease	7.77e-05	0.000304	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CREB1—Alzheimer's disease	7.71e-05	0.000302	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—INS—Alzheimer's disease	7.67e-05	0.0003	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—Alzheimer's disease	7.54e-05	0.000295	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1R—Alzheimer's disease	7.54e-05	0.000295	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1R—Alzheimer's disease	7.54e-05	0.000295	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CALM1—Alzheimer's disease	7.47e-05	0.000293	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—Alzheimer's disease	7.45e-05	0.000292	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—LPL—Alzheimer's disease	7.44e-05	0.000291	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1—Alzheimer's disease	7.42e-05	0.00029	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CAV1—Alzheimer's disease	7.38e-05	0.000289	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—Alzheimer's disease	7.29e-05	0.000286	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LPL—Alzheimer's disease	7.23e-05	0.000283	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LPL—Alzheimer's disease	7.23e-05	0.000283	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MEF2C—Alzheimer's disease	7.17e-05	0.000281	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MEF2C—Alzheimer's disease	7.17e-05	0.000281	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	7.12e-05	0.000279	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCG—Alzheimer's disease	7.03e-05	0.000275	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCG—Alzheimer's disease	7.03e-05	0.000275	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS2—Alzheimer's disease	6.94e-05	0.000272	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOTCH1—Alzheimer's disease	6.87e-05	0.000269	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGF—Alzheimer's disease	6.85e-05	0.000268	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGF—Alzheimer's disease	6.85e-05	0.000268	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—Alzheimer's disease	6.72e-05	0.000263	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—Alzheimer's disease	6.7e-05	0.000262	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—Alzheimer's disease	6.66e-05	0.000261	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—Alzheimer's disease	6.66e-05	0.000261	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2A—Alzheimer's disease	6.52e-05	0.000255	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2A—Alzheimer's disease	6.52e-05	0.000255	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GSK3B—Alzheimer's disease	6.45e-05	0.000252	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CREB1—Alzheimer's disease	6.4e-05	0.00025	CbGpPWpGaD
Alprostadil—ABCC5—Disease—INS—Alzheimer's disease	6.36e-05	0.000249	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CALM1—Alzheimer's disease	6.26e-05	0.000245	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—Alzheimer's disease	6.24e-05	0.000244	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAV1—Alzheimer's disease	6.18e-05	0.000242	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT1—Alzheimer's disease	6.16e-05	0.000241	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CALM1—Alzheimer's disease	6.08e-05	0.000238	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CALM1—Alzheimer's disease	6.08e-05	0.000238	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—Alzheimer's disease	6.06e-05	0.000237	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—Alzheimer's disease	6.06e-05	0.000237	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LEP—Alzheimer's disease	6.06e-05	0.000237	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LEP—Alzheimer's disease	6.06e-05	0.000237	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CAV1—Alzheimer's disease	6.01e-05	0.000235	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CAV1—Alzheimer's disease	6.01e-05	0.000235	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ESR1—Alzheimer's disease	5.79e-05	0.000227	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ESR1—Alzheimer's disease	5.79e-05	0.000227	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.76e-05	0.000226	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—Alzheimer's disease	5.75e-05	0.000225	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2—Alzheimer's disease	5.72e-05	0.000224	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2—Alzheimer's disease	5.72e-05	0.000224	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CASP3—Alzheimer's disease	5.71e-05	0.000224	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—Alzheimer's disease	5.67e-05	0.000222	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH1—Alzheimer's disease	5.6e-05	0.000219	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.6e-05	0.000219	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—Alzheimer's disease	5.58e-05	0.000218	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—Alzheimer's disease	5.43e-05	0.000213	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—INS—Alzheimer's disease	5.33e-05	0.000209	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB1—Alzheimer's disease	5.28e-05	0.000207	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GSK3B—Alzheimer's disease	5.25e-05	0.000206	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GSK3B—Alzheimer's disease	5.25e-05	0.000206	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK8—Alzheimer's disease	5.25e-05	0.000205	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT1—Alzheimer's disease	5.23e-05	0.000205	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CREB1—Alzheimer's disease	5.21e-05	0.000204	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CREB1—Alzheimer's disease	5.21e-05	0.000204	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INS—Alzheimer's disease	5.18e-05	0.000203	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INS—Alzheimer's disease	5.18e-05	0.000203	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—Alzheimer's disease	5.1e-05	0.0002	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—Alzheimer's disease	5.1e-05	0.0002	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—Alzheimer's disease	5.1e-05	0.0002	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1—Alzheimer's disease	5.01e-05	0.000196	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1—Alzheimer's disease	5.01e-05	0.000196	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—Alzheimer's disease	4.84e-05	0.00019	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—Alzheimer's disease	4.67e-05	0.000183	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—Alzheimer's disease	4.54e-05	0.000178	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—Alzheimer's disease	4.54e-05	0.000178	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFB1—Alzheimer's disease	4.45e-05	0.000174	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—Alzheimer's disease	4.35e-05	0.00017	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—Alzheimer's disease	4.27e-05	0.000167	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.89e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT1—Alzheimer's disease	3.89e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CASP3—Alzheimer's disease	3.86e-05	0.000151	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CASP3—Alzheimer's disease	3.86e-05	0.000151	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—Alzheimer's disease	3.83e-05	0.00015	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—Alzheimer's disease	3.83e-05	0.00015	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFB1—Alzheimer's disease	3.69e-05	0.000144	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT1—Alzheimer's disease	3.67e-05	0.000144	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—Alzheimer's disease	3.66e-05	0.000143	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK8—Alzheimer's disease	3.54e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK8—Alzheimer's disease	3.54e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT1—Alzheimer's disease	3.53e-05	0.000138	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT1—Alzheimer's disease	3.53e-05	0.000138	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—Alzheimer's disease	3.35e-05	0.000131	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—Alzheimer's disease	3.27e-05	0.000128	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—Alzheimer's disease	3.27e-05	0.000128	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT1—Alzheimer's disease	3.09e-05	0.000121	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFB1—Alzheimer's disease	3e-05	0.000118	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFB1—Alzheimer's disease	3e-05	0.000118	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—Alzheimer's disease	2.78e-05	0.000109	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT1—Alzheimer's disease	2.56e-05	0.0001	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—Alzheimer's disease	2.47e-05	9.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—Alzheimer's disease	2.47e-05	9.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—Alzheimer's disease	2.26e-05	8.86e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—Alzheimer's disease	2.26e-05	8.86e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKT1—Alzheimer's disease	2.15e-05	8.41e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT1—Alzheimer's disease	2.09e-05	8.18e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT1—Alzheimer's disease	2.09e-05	8.18e-05	CbGpPWpGaD
